Invivyd Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Recent Business Highlights
PEMGARDA™ (pemivibart) net product revenue of $13.8 million, representing 48% growth over Q3 2024 net product revenue of $9.3 ...
Invivyd reports FY24 EPS ($1.43) vs. ($1.81) last year
Reports FY24 revenue $25.3M, consensus $25.15M. “We are pleased with the significant PEMGARDA revenue growth of 48% in the fourth quarter, ...
Zacks Investment Research on MSN7h
Invivyd, Inc. (IVVD) Reports Q4 Loss, Tops Revenue Estimates
Invivyd, Inc. (IVVD) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to loss of $0.67 per share a year ago. These figures are ...
Insider Monkey18d
Why Invivyd, Inc. (IVVD) is Skyrocketing So Far in 2025
In this article, we are going to take a look at where Invivyd, Inc. (NASDAQ:IVVD) stands against the other biotech stocks. No matter the market environment, you’ll always find entertainment in ...
Yahoo Finance6d
Invivyd, Inc. (IVVD)
2; affirms structural biology within Invivyd’s unique technology and reflects consi Invivyd (NasdaqGM:IVVD) has seen its share price surge by an impressive 163% over the past month, driven ...
Nasdaq15d
Invivyd, Inc. Reports Positive In Vitro Neutralization Data for PEMGARDA™ Against Dominant SARS-CoV-2 Variant LP.8.1
Invivyd, Inc. has announced new in vitro data showing that its monoclonal antibody PEMGARDA™ (pemivibart) maintains effective neutralizing activity against the prevalent LP.8.1 variant of SARS ...
Nasdaq15d
Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Currently Dominant SARS-CoV-2 Variant LP.8.1
WALTHAM, Mass., March 05, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced positive, continued, clinically meaningful in vitro neutralization data for PEMGARDA™ (pemivibart ...
Insider Monkey1mon
Why Invivyd, Inc. (IVVD) Is Soaring This Year So Far
In this article, we are going to take a look at where Invivyd, Inc. (NASDAQ:IVVD) stands against the other micro and small-cap stocks. Nine micro-cap companies and one small-cap firm have been the ...
ETF Daily News22d
Invivyd (NASDAQ:IVVD) Earns “Buy” Rating from HC Wainwright
Invivyd (NASDAQ:IVVD – Get Free Report) ‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright in a report issued on Monday,Benzinga reports.They currently ...
MarketWatch24d
Invivyd Shares Down as Regulators Decline Expanded Use for Covid-19 Treatment
Invivyd's stock fell sharply in pre-market trading Monday after U.S. regulators denied a request for its drug Pemgarda to be used in treating Covid-19 in more cases. Shares traded 37% lower ahead ...
Yahoo Finance17d
Invivyd, Inc. (IVVD)
Feb. 10, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that Marc Elia, Chairman of the Invivyd Board of Directors, will be presenting at the Oppenheimer 35th Annual ...